CANDIE BOOKS: Open Payments
NPI 1194334631 · PLYMOUTH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,812 in 226 payments from 42 companies in 2025. Trend: 2023 $3,842 · 2024 $4,547 · 2025 $4,812
Food & beverage: $4,647Education: $165
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $933 |
| Vanda Pharmaceuticals Inc. | 13 | $366 |
| PFIZER INC. | 15 | $305 |
| Janssen Biotech, Inc. | 8 | $280 |
| Novartis Pharmaceuticals Corporation | 6 | $205 |
| UCB, Inc. | 10 | $163 |
| CATALYST PHARMACEUTICALS, INC. | 8 | $162 |
| Biogen, Inc. | 12 | $161 |
| Lundbeck LLC | 10 | $157 |
| Mallinckrodt Hospital Products Inc. | 8 | $150 |
Products named: UBRELVY, QULIPTA, PONVORY, KESIMPTA, REXULTI, NURTEC ODT, TYSABRI, ACTHAR.
Industry payments across IN — which companies pay providers there.
